Department of Surgery, University Hospital of Larissa, Mezourlo, 41110, Larissa, Greece.
Department of Surgery, General Hospital of Volos, Polymeri 134, 38222, Volos, Greece.
J Gastrointest Cancer. 2023 Sep;54(3):782-790. doi: 10.1007/s12029-022-00862-8. Epub 2022 Sep 5.
Defunctioning ileostomies are often performed during rectal cancer surgery. However, stomas are sometimes associated with complications, while 20-30% of them are never reversed. Additionally, ileostomy closure can have associated morbidity, with rates as high as 45%, with the respective literature evidence being scarce and conflicting. Thus, we evaluated the stoma reversal outcomes and the risk factors for non-closure after rectal cancer surgery.
This is a retrospective analysis of a prospectively collected database of all patients who had a defunctioning ileostomy at the time of resection for rectal cancer. All operations were performed by the same surgical team. A multivariable regression model was implemented.
In this study, 129 patients (male: 68.2%, female: 31.8%) were included. Ileostomy formation was associated with a total of 31% complication rate. Eventually 73.6% of the stomas were reversed at a mean time to closure of 26.6 weeks, with a morbidity of 13.7%. Non-reversal of ileostomy was correlated with neoadjuvant CRT (OR: 0.093, 95% CI: 0.012-0.735), anastomotic leakage (OR: 0.107, 95% CI: 0.019-0.610), and lymph node yield (OR: 0.946, 95% CI: 0.897-0.998). Time to reversal was affected by the N status, the LNR, the need for adjuvant chemotherapy, and the histologic grade.
In patients with rectal cancer resections, defunctioning stoma closure rate and time to closure were associated with several perioperative and pathological outcomes.
在直肠癌手术中,常施行预防性回肠造口术。然而,造口有时会出现并发症,且有 20-30%的造口无法还纳。此外,回肠造口关闭术也会带来相关并发症,发生率高达 45%,但相关文献证据稀缺且存在矛盾。因此,我们评估了直肠癌手术后造口还纳的结果以及无法还纳的危险因素。
这是对所有因直肠癌行切除术时行预防性回肠造口术患者的前瞻性收集数据库的回顾性分析。所有手术均由同一手术团队完成。采用多变量回归模型。
本研究共纳入 129 例患者(男性:68.2%,女性:31.8%)。造口术总并发症发生率为 31%。最终,129 例患者中有 73.6%的患者在平均 26.6 周时进行了造口还纳,造口还纳的并发症发生率为 13.7%。造口无法还纳与新辅助放化疗(OR:0.093,95%CI:0.012-0.735)、吻合口漏(OR:0.107,95%CI:0.019-0.610)和淋巴结检出数(OR:0.946,95%CI:0.897-0.998)相关。造口还纳时间受到 N 分期、淋巴结转移率、辅助化疗的需要以及组织学分级的影响。
在接受直肠癌切除术的患者中,预防性回肠造口关闭率和关闭时间与多种围手术期和病理结局相关。